Literature DB >> 12564734

Influence of host factors on survival in dogs with malignant mammary gland tumors.

Jeffrey C Philibert1, Paul W Snyder, Nita Glickman, Larry T Glickman, Deborah W Knapp, David J Waters.   

Abstract

The purpose of our study was to determine if specific host factors, such as age at diagnosis, obesity, and hormone status, influence the prognosis of canine mammary gland carcinomas and to confirm if previously reported risk factors (ie, histologic subtype, tumor size, and World Health Organization [WHO] stage) were important in a large series of affected dogs. Ninety-nine female dogs with mammary gland carcinomas, no previous therapy, an excisional biopsy, and known cause of death were studied. No significant association with survival was noted for age at diagnosis (chronologic or physiologic), obesity, or hormone status (ie, spayed versus intact, regardless of time of being spayed). Of the tumor factors analyzed, the histologic subtype anaplastic carcinoma (P = .02), WHO stage I (P = .01), evidence of metastasis at the time of diagnosis (P = .004), and tumor size of 3 cm or smaller (P = .005) all significantly influenced survival. Dogs that were classified as having tumor-related mortality had a shorter postoperative survival compared to dogs that died of other causes (14 months versus 23 months; P = .03). In conclusion, histologic subtype, WHO stage, and tumor size remain important prognostic factors in canine mammary gland tumors. Further study of other prognostic factors is needed to determine which tumors are adequately addressed with local therapy only and which dogs may require adjuvant treatment with chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12564734     DOI: 10.1892/0891-6640(2003)017<0102:iohfos>2.3.co;2

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  26 in total

Review 1.  Impact of obesity on development and progression of mammary tumors in preclinical models of breast cancer.

Authors:  Margot P Cleary
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-12       Impact factor: 2.673

2.  Clinical staging in bitches with mammary tumors: Influence of type and histological grade.

Authors:  Lígia F Gundim; Camila P de Araújo; William T Blanca; Ednaldo C Guimarães; Alessandra A Medeiros
Journal:  Can J Vet Res       Date:  2016-10       Impact factor: 1.310

3.  B-mode ultrasound examination of canine mammary gland neoplastic lesions of small size (diameter < 2 cm).

Authors:  Iacopo Vannozzi; Matteo Tesi; Marta Zangheri; Viola Maria Innocenti; Alessandra Rota; Simonetta Citi; Alessandro Poli
Journal:  Vet Res Commun       Date:  2018-03-14       Impact factor: 2.459

4.  MicroRNA expression in canine mammary cancer.

Authors:  R Michelle Boggs; Zachary M Wright; Mark J Stickney; Weston W Porter; Keith E Murphy
Journal:  Mamm Genome       Date:  2008-07-30       Impact factor: 2.957

5.  Immunophenotypic features of tumor infiltrating lymphocytes from mammary carcinomas in female dogs associated with prognostic factors and survival rates.

Authors:  Alessandra Estrela-Lima; Márcio S S Araújo; João M Costa-Neto; Andréa Teixeira-Carvalho; Stella M Barrouin-Melo; Sergio V Cardoso; Olindo A Martins-Filho; Rogéria Serakides; Geovanni D Cassali
Journal:  BMC Cancer       Date:  2010-06-04       Impact factor: 4.430

6.  CA 15-3 cell lines and tissue expression in canine mammary cancer and the correlation between serum levels and tumour histological grade.

Authors:  Elisabetta Manuali; Antonio De Giuseppe; Francesco Feliziani; Katia Forti; Cristina Casciari; Maria Chiara Marchesi; Eugenio Pacifico; Karol M Pawłowski; Kinga Majchrzak; Magdalena Król
Journal:  BMC Vet Res       Date:  2012-06-22       Impact factor: 2.741

7.  Endocrine control of canine mammary neoplasms: serum reproductive hormone levels and tissue expression of steroid hormone, prolactin and growth hormone receptors.

Authors:  Michèle Spoerri; Franco Guscetti; Sonja Hartnack; Alois Boos; Christine Oei; Orsolya Balogh; Renata M Nowaczyk; Erika Michel; Iris M Reichler; Mariusz P Kowalewski
Journal:  BMC Vet Res       Date:  2015-09-15       Impact factor: 2.741

8.  Identification of prognostic factors in canine mammary malignant tumours: a multivariable survival study.

Authors:  Andreia A Santos; Célia C Lopes; Jorge R Ribeiro; Liliana R Martins; Joana C Santos; Irina F Amorim; Fátima Gärtner; Augusto J Matos
Journal:  BMC Vet Res       Date:  2013-01-04       Impact factor: 2.741

9.  Relationship between major histocompatibility complex class I expression and prognosis in canine mammary gland tumors.

Authors:  Toshiyuki Tanaka; Terumasa Shimada; Hideo Akiyoshi; Junichiro Shimizu; Cao Zheng; Li Yijyun; Keiichiro Mie; Akiyoshi Hayashi; Mitsuru Kuwamura; Fumio Hoshi; Fumihito Ohashi
Journal:  J Vet Med Sci       Date:  2013-05-31       Impact factor: 1.267

10.  The relationship between clinicopathological features and expression of epithelial and mesenchymal markers in spontaneous canine mammary gland tumors.

Authors:  Kota Yoshida; Saori Yoshida; Nan Choisunirachon; Tomochika Saito; Kaori Matsumoto; Kohei Saeki; Manabu Mochizuki; Ryohei Nishimura; Nobuo Sasaki; Takayuki Nakagawa
Journal:  J Vet Med Sci       Date:  2014-06-16       Impact factor: 1.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.